Related Experiment Video
Updated: Jul 10, 2025

04:29
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
28.6K
App-Based Interventions for Moderate to Severe Depression: A Systematic Review and Meta-Analysis
Hayoung Bae1, Hyemin Shin2, Han-Gil Ji1
1School of Psychology, Korea University, Seoul, Republic of Korea.
JAMA Network Open
|November 20, 2023
Summary
Mobile mental health apps effectively treat moderate to severe depression. Shorter interventions and those without notifications show better outcomes for depression symptom severity.
Area of Science:
- Digital mental health
- Psychiatry
- Computational social science
Background:
- Mobile mental health applications (apps) are increasingly used for treating moderate to severe depression, offering an alternative to traditional psychotherapy.
- Research on factors influencing the efficacy of these mobile app interventions is limited.
Approach:
- A systematic review and meta-analysis of randomized clinical trials published in English was conducted.
- Studies were identified through searches of PubMed, Embase, and PsycINFO up to January 2023.
- Data extraction and analysis followed PRISMA guidelines, including risk of bias and intervention component assessment.
Key Points:
- The analysis included 13 studies with 1470 participants, evaluating 16 different mobile apps.
- Mobile app interventions demonstrated a pooled effect size of 0.50 (95% CI, 0.40 to 0.61) compared to control groups.
- Interventions delivered for less than 8 weeks showed significantly greater effect sizes (SMD, 0.77) than longer interventions (SMD, 0.43).
- Apps utilizing in-app notifications had lower treatment outcomes (SMD, 0.45) compared to those without (SMD, 0.71).
Conclusions:
- Mobile app interventions are feasible and effective for treating moderate to severe depression.
- Intervention duration and the use of in-app notifications are key moderators of treatment efficacy.
- Findings provide practical guidance for developing more effective app-based mental health interventions.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
248
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
248
Depression: Overview
254
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
254
Antidepressant Drugs: Overview
516
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
516
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
403
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
403
Depressive Disorders: MDD and Dysthymia
136
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
136
Cognitive Therapy
153
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
153

